E.Coli research to get €2 million EU investment

By Admin
Over €2 million, equal to $3 millionwill be invested into research of a new E.Coli strain by the European Union (EU). Approximately 4,000 European...

Over €2 million, equal to $3 million will be invested into research of a new E.Coli strain by the European Union (EU).

Approximately 4,000 Europeans were infected with the new strain of E.Coli earlier this year and 51 people died.

The outbreak of the food-borne bacteria caused huge financial losses to vegetable farmers across Europe after it was linked to cucumbers and other EU vegetables.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Russia imports approximately €600 million worth of EU vegetables a year but it banned such activities on June 2 after they were suspected of carrying the E.Coli virus.

The source of the E.Coli outbreak was eventually indentified as being Egyptian fenugreek seeds and vegetable farmers across Europe are now hoping to receive €227 million in compensation.

The EU now wants to “get as full a scientific picture as possible” of the strain to help organise effective preventions and responses in the future.

The investment is part of the €12 million project designed to reinforce Europe’s ability to outbreaks of this nature.

In a statement the European Commission said: “the research will focus on ways to prevent future epidemics and deal with new outbreaks.”

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma